Story perspectives

Study Challenges Age-Based Treatment in Acute Myeloid Leukemia

10/15/2025

33 5

Summary

Story summary

An international study by the Alliance for Clinical Trials in Oncology and the Acute Myeloid Leukemia Cooperative Group challenges traditional age-based AML treatment.
Analyzing data from 2,823 patients in the United States and Germany, researchers show chronological age does not reliably predict biology or prognosis.
They found five-year survival drops from 73% among young adults to 21% in those aged 75 and older, indicating continuous age-related differences.

1 of 1

Story summary

An international study by the Alliance for Clinical Trials in Oncology and the Acute Myeloid Leukemia Cooperative Group challenges traditional age-based AML treatment.
Analyzing data from 2,823 patients in the United States and Germany, researchers show chronological age does not reliably predict biology or prognosis.
They found five-year survival drops from 73% among young adults to 21% in those aged 75 and older, indicating continuous age-related differences.